This document summarizes research on the immune response to cytomegalovirus (CMV) and cancer-testis antigens (CTAgs). It discusses how CMV elicits a massive immune response, occupying up to 40% of CD8+ T cells. This response declines with immunosuppression. It also explores using CMV-specific T cells for immunotherapy after stem cell transplantation. The document then examines CTAgs, which are expressed in cancers and elicit anti-tumor immune responses, but challenges remain in understanding their efficacy.
3. - HIV+ donors - Cloned HIV-specific CTL - Cloned TCR - cDNA from PBMC was probed with oligos for TCRs - Suggested effector frequency of 0.2 - 1%
4. Led to collaboration on use of new reagents to study T cell immune responses Viral Antigen Fluorescence T Cell
5. We could visualise HIV-specific T cells Altman, Moss et al Science. 1996 Oct 4;274(5284):94-6.Phenotypic analysis of antigen-specific T lymphocytes.
6.
7. Herpes viruses Group of eight viruses HSV I & II, EBV, VZV, CMV, HHV-6 HHV-7, HHV-8
13. Age Percentage of CD8+ T cell response Khan et al , J.I. 2004 The CD8-specific T cell response to CMV increases with age DE F P=0.0352 P0.0067 P=0.0159 P=0.07262 P=0.003
14. How does CMV change the memory and naïve T cell count in healthy people ? T cells Naive Memory
23. Sometimes the initial (primary) infection with CMV can cause clinical problems “ I though it was the end of my tennis. Even as a person I could feel myself changing. I just wanted to stay and home and not see anyone, not even my friends. But slowly I got better. I still have to be careful and I can’t train or work as hard as I once did” Justine Henin-Hardenne
28. CMV was a major cause of death in the early days of stem cells transplantation CMV pneumonitis
29. Patients have very few CMV-specific T cells in the first three months following SCT Time post-SCT Number of CMV-specific T cells
30. Is it possible to transfer T cells into the patient to correct the early period of immunodeficiency ? CMV-specific T cells
31. BMT is the ideal setting for adoptive transfer of T cells D D P P Time Following SCT, the patient is immunologically tolerant of cells taken from the donor
32. Use tetramers to bind to CMV-specific T cells in the donor Stain T cells FACS analysis T Cell PE
33. T cells that bind tetramer can be selected with magnetic beads T Cell PE
34. Transferred T cells can expand and clear CMV viraemia ( Cobbold et al, JEM 2005) 2.10 6 CMV-specific T cells were given 99.5% Pre-infusion blood sample 0% • Prior to infusion the patient had CMV viraemia • No CMV-specific T cells were present 0.5% 9 days later T cells were present and the patient became CMV negative Blood sample 9 days after infusion
51. Tumour regression following vaccination MAGE antigens in a melanoma patient Evolution of skin metastases on the leg of patient EB81 during treatment. van Baren N et al 2005 (A) (B) (C) (A) Before vaccination (B) After four vaccinations with ALVAC (after 3 months) (C) After 10 months
52.
53.
54. PBMCs only PBMCs + RVRF PRE POST 0.05% 0.01% 0.00008 0.004 Example of CTAg-specific cell responses in myeloma CD8 IFN
55.
56.
57.
58. The CD8 response actually increases in the terminal stages of disease
59. MAGE – specific CD8 T cell clones can kill tumour when they are cloned in vitro (iii) (ii)
71. 2000- renal transplant patient developed melanoma in kidney and breast 2000 - another transplant patient 2 developed melanoma in kidney - Registry showed both patients had been transplanted from same patient in 1998 - This patient had received excision of 2.6mm melanoma in 1982 Tumour latency Mackie 2003
72.
73.
74.
75.
76.
77.
78.
Hinweis der Redaktion
If an antigen which had been labelled, for instance with a fluorescent dye, could be directly bound to T cells then the antigen-specific cells could be detected directly.
Once these complexes are made they can bind to a T cell specific for the peptide which was been inserted in the multimeric complex and then these T cells can be detected on a FACS machine by the fluoresecnce that they emit.
Once these complexes are made they can bind to a T cell specific for the peptide which was been inserted in the multimeric complex and then these T cells can be detected on a FACS machine by the fluoresecnce that they emit.